• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.

作者信息

Wilhelm Christian, Neubauer Andreas, Burchert Andreas

出版信息

Leuk Lymphoma. 2011 Oct;52(10):2031-5. doi: 10.3109/10428194.2011.588760. Epub 2011 Jun 24.

DOI:10.3109/10428194.2011.588760
PMID:21702642
Abstract
摘要

相似文献

1
Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.对于高危急性髓系白血病患者，在接受氟达拉滨、阿糖胞苷和安吖啶减低强度预处理后，不良风险细胞遗传学可能与较差的预后相关。
Leuk Lymphoma. 2011 Oct;52(10):2031-5. doi: 10.3109/10428194.2011.588760. Epub 2011 Jun 24.
2
Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.氟达拉滨、安吖啶和阿糖胞苷联合治疗高危急性髓系白血病患者，随后进行低强度预处理和异基因造血干细胞移植。
Ann Hematol. 2013 Oct;92(10):1397-403. doi: 10.1007/s00277-013-1790-5. Epub 2013 Jun 1.
3
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.接受氟达拉滨、阿糖胞苷和安吖啶联合治疗后进行减低强度预处理及异基因干细胞移植的难治性急性髓系白血病患者预后的危险因素。
J Cancer Res Clin Oncol. 2016 Jan;142(1):317-24. doi: 10.1007/s00432-015-2050-y. Epub 2015 Sep 30.
4
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.高危急性髓系白血病和骨髓增生异常综合征的化疗序贯方案、异基因干细胞移植的减低强度预处理及预防性供者淋巴细胞输注
J Clin Oncol. 2005 Aug 20;23(24):5675-87. doi: 10.1200/JCO.2005.07.061.
5
[Efficacy of FLAG as initial induction chemotherapy followed by autologous hematopoietic stem cell transplantation after IBu conditioning regimen in acute myeloid leukemia with FLT3 mutations].
Zhonghua Xue Ye Xue Za Zhi. 2014 Jul;35(7):653-5. doi: 10.3760/cma.j.issn.0253-2727.2014.07.019.
6
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.氟达拉滨、阿糖胞苷、粒细胞集落刺激因子和安吖啶：初发复发急性髓细胞白血病的有效挽救治疗选择。
Leuk Lymphoma. 2013 Feb;54(2):336-41. doi: 10.3109/10428194.2012.713479. Epub 2012 Sep 8.
7
Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.序贯强化预处理方案异基因造血干细胞移植治疗完全缓解的中高危成人急性髓系白血病：欧洲血液与骨髓移植组急性白血病工作组的一项研究
Biol Blood Marrow Transplant. 2017 Feb;23(2):278-284. doi: 10.1016/j.bbmt.2016.11.002. Epub 2016 Nov 2.
8
Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.采用基于 FLAMSA 的大剂量序贯预处理方案对高危骨髓增生异常综合征或继发性急性髓系白血病患者进行 upfront 同种异体造血干细胞移植。
Biol Blood Marrow Transplant. 2012 Mar;18(3):466-72. doi: 10.1016/j.bbmt.2011.09.006. Epub 2011 Sep 29.
9
Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.氟达拉滨与阿糖胞苷联合用于诱导成年急性髓系白血病患者治疗
Acta Haematol. 2017;137(1):15-16. doi: 10.1159/000449277. Epub 2016 Nov 3.
10
Facts about FCE (fludarabine, cytarabine, etoposide) in acute myeloid leukemia.关于氟达拉滨、阿糖胞苷、依托泊苷（FCE）治疗急性髓系白血病的事实。
Acta Haematol. 2014;131(4):200-1. doi: 10.1159/000355134. Epub 2013 Nov 27.